BRAF Inhibitor-Driven Tumor Proliferation in a KRAS-Mutated Colon Carcinoma Is Not Overcome by MEK1/2 Inhibition

被引：43
|
作者：
Andrews, Miles C. [1 ]
Behren, Andreas [2 ]
Chionh, Fiona [2 ]
Mariadason, John [2 ]
Vella, Laura J. [2 ]
Do, Hongdo [3 ]
Dobrovic, Alexander [3 ]
Tebbutt, Niall [1 ]
Cebon, Jonathan [1 ]
机构：
[1] Austin Hlth, Joint Ludwig Austin Oncol Unit, Melbourne, Vic, Australia
[2] Ludwig Inst Canc Res, Austin Branch, Melbourne, Vic, Australia
[3] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 35期
关键词：
SQUAMOUS-CELL CARCINOMAS; ADVANCED MELANOMA; RAF INHIBITORS; MUTATIONS; SURVIVAL; V600E;
D O I：
10.1200/JCO.2013.50.4118
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：E448 / E451
页数：4
相关论文
共 50 条
  • [21] Characterizing a Canine Urothelial Carcinoma Model of Acquired MEK1/2 Inhibitor Resistance
    Duval, Dawn L.
    Idate, Rupa
    Das, Sunetra
    Ackart, David
    Gustafson, Daniel L.
    Cronise, Kathryn
    FASEB JOURNAL, 2022, 36
  • [22] PB1, a DDR2 inhibitor with antitumor activity in preclinical models of squamous cell carcinoma and KRAS-mutated adenocarcinoma of the lung
    Garcia-Roman, Silvia
    Molina, Miguel Angel
    Borrell, Jose Ignacio
    de la Bellacasa, Raimon Puig
    Morales, Daniela
    Bertran, Jordi
    Gimenez, Ana
    Karachaliou, Niki
    Rosell, Rafael
    CANCER RESEARCH, 2016, 76
  • [23] EFFECTS OF TORC1/2 INHIBITOR MLN0128 ALONE AND IN COMBINATION WITH MEK INHIBITION IN BRAF MUTATED GLIOMA CELLS
    Mueller, Sabine
    Dik, Rogier
    Yang, Xiaodong
    Aleksandra, Ola
    Gustafson, Clay
    DuBois, Steve
    Weiss, William
    Waanders, Angela
    Resnick, Adam
    Haas-Kogan, Daphne
    NEURO-ONCOLOGY, 2015, 17 : 19 - 19
  • [24] CTC BIOMARKER ASSESSMENT TO AID DOSING SELECTION OF E6201, A POTENTIAL MEK1 INHIBITOR, FOR TREATMENT OF BRAF-MUTATED MELANOMA
    Eisen, A.
    Akerele, C.
    Reyderman, L.
    Verbel, D. A.
    Simon, J. S.
    Davis, D. W.
    Nomoto, K.
    Wang, J.
    ANNALS OF ONCOLOGY, 2010, 21 : 405 - 405
  • [25] CRISPR/Cas9 Edited RAS & MEK Mutant Cells Acquire BRAF and MEK Inhibitor Resistance with MEK1 Q56P Restoring Sensitivity to MEK/BRAF Inhibitor Combo and KRAS G13D Gaining Sensitivity to Immunotherapy
    Turner, Elizabeth
    Chen, Luping
    Foulke, John G.
    Gu, Zhizhan
    Tian, Fang
    CANCERS, 2022, 14 (21)
  • [26] MEK1/2 specific inhibitor, SMK-17 selectively induces apoptosis in β-catenin mutated tumors
    Kiga, M.
    Nakayama, A.
    Sasazawa, Y.
    Shikata, Y.
    Ikeda, H.
    Tashiro, E.
    Imoto, M.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : 176 - 176
  • [27] Fibronectin Contributes to a BRAF Inhibitor-driven Invasive Phenotype in Thyroid Cancer through EGR1, Which Can Be Blocked by Inhibition of ERK1/2
    Hicks, Hannah M.
    Pozdeyev, Nikita
    Sams, Sharon B.
    Pugazhenthi, Umarani
    Bales, Elise S.
    Hofmann, Marie -Claude
    McKenna, Logan R.
    Schweppe, Rebecca E.
    MOLECULAR CANCER RESEARCH, 2023, 21 (09) : 867 - 880
  • [28] The MEK1/2 Inhibitor AS703026 Circumvents Resistance to the BRAF Inhibitor PLX4032 in Human Malignant Melanoma Cells
    Park, Seong Joon
    Hong, Seung-Woo
    Moon, Jai-Hee
    Jin, Dong-Hoon
    Kim, Jin-Sun
    Lee, Chang-Kyu
    Kim, Kyu-pyo
    Hong, Yong Sang
    Choi, Eun Kyung
    Lee, Jung Shin
    Lee, Jae-Lyun
    Kim, Tae Won
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2013, 346 (06): : 494 - 498
  • [29] Correction: Corrigendum: Targeting BMK1 Impairs the Drug Resistance to Combined Inhibition of BRAF and MEK1/2 in Melanoma
    Chengli Song
    Lina Wang
    Qiang Xu
    Kai Wang
    Dan Xie
    Zhe Yu
    Kui Jiang
    Lujian Liao
    John R. Yates
    Jiing-Dwan Lee
    Qingkai Yang
    Scientific Reports, 7
  • [30] Disruption of thioredoxin metabolism enhances the toxicity of transforming growth factor β-activated kinase 1 (TAK1) inhibition in KRAS-mutated colon cancer cells
    Hrabe, Jennifer E.
    O'Leary, Brianne R.
    Fath, Melissa A.
    Rodman, Samuel N.
    Button, Anna M.
    Domann, Frederick E.
    Spitz, Douglas R.
    Mezhir, James J.
    REDOX BIOLOGY, 2015, 5 : 319 - 327
12345